| Delivery of anti-miRNA for triple-negative breast cancer therapy using RNA nanoparticles targeting stem cell marker CD133 H Yin, G Xiong, S Guo, C Xu, R Xu, P Guo, D Shu Molecular Therapy 27 (7), 1252-1261, 2019 | 153 | 2019 |
| Algorithm for optimized mRNA design improves stability and immunogenicity H Zhang, L Zhang, A Lin, C Xu, Z Li, K Liu, B Liu, X Ma, F Zhao, H Jiang, ... Nature 621 (7978), 396-403, 2023 | 133 | 2023 |
| Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping Z Zheng, Z Li, C Xu, B Guo, P Guo Journal of Controlled Release 311, 43-49, 2019 | 119 | 2019 |
| Self-assembled DNA nanocentipede as multivalent drug carrier for targeted delivery W Li, X Yang, L He, K Wang, Q Wang, J Huang, J Liu, B Wu, C Xu ACS applied materials & interfaces 8 (39), 25733-25740, 2016 | 94 | 2016 |
| Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy C Xu, F Haque, DL Jasinski, DW Binzel, D Shu, P Guo Cancer letters 414, 57-70, 2018 | 76 | 2018 |
| RNA nanoparticles as rubber for compelling vessel extravasation to enhance tumor targeting and for fast renal excretion to reduce toxicity C Ghimire, H Wang, H Li, M Vieweger, C Xu, P Guo ACS nano 14 (10), 13180-13191, 2020 | 54 | 2020 |
| Tuning the Size, Shape, and Structure of RNA Nanoparticles for Favorable Cancer Targeting and Immunostimulation 1 S Guo, C Xu, H Yin, P Guo, J Hill, F Pi RNA Nanotechnology and Therapeutics, 543-562, 2022 | 52 | 2022 |
| Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression Y Xu, L Pang, H Wang, C Xu, H Shah, P Guo, D Shu, SY Qian Redox biology 21, 101085, 2019 | 46 | 2019 |
| Photo-controlled release of paclitaxel and model drugs from RNA pyramids C Xu, H Li, K Zhang, DW Binzel, H Yin, W Chiu, P Guo Nano research 12, 41-48, 2019 | 46 | 2019 |
| Lineardesign: Efficient algorithms for optimized mrna sequence design H Zhang, L Zhang, A Lin, C Xu, Z Li, K Liu, B Liu, X Ma, F Zhao, W Yao, ... | 13 | 2021 |
| Construction of RNA nanotubes H Li, S Wang, Z Ji, C Xu, LS Shlyakhtenko, P Guo Nano research 12, 1952-1958, 2019 | 10 | 2019 |
| Using planar Phi29 pRNA three-way junction to control size and shape of RNA nanoparticles for biodistribution profiling in mice F Haque, C Xu, DL Jasinski, H Li, P Guo RNA Nanostructures: Methods and Protocols, 359-380, 2017 | 9 | 2017 |
| Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel … Y Fang, JX Li, D Duangdany, Y Li, XL Guo, C Phamisith, B Yu, MY Shen, ... EClinicalMedicine 67, 2024 | 5 | 2024 |
| 3D RNA nanocage for encapsulation and shielding of hydrophobic biomolecules to improve the in vivo biodistribution C Xu, K Zhang, H Yin, Z Li, A Krasnoslobodtsev, Z Zheng, Z Ji, S Guo, S Li, ... Nano research 13, 3241-3247, 2020 | 5 | 2020 |
| Regulation of reversible conformational change, size switching, and immunomodulation of RNA nanocubes PJB Carcache, S Guo, H Li, K Zhang, C Xu, W Chiu, P Guo RNA 27 (9), 971-980, 2021 | 2 | 2021 |
| Targeted delivery of drug molecules with drug ligands conjugated to rna nanoparticle motion elements P Guo, D Binzel, PB CARCACHE, X Li, XU Congcong US Patent App. 18/170,997, 2024 | | 2024 |
| Improving the Circularization Efficiency, Stability and Translatability of Circular RNA by circDesign C Xu, L Zhang, W Wang, Y Tang, Q Wang, J An, H Xu, Y Ge, H Zhu, ... bioRxiv, 2023.07. 09.548293, 2023 | | 2023 |
| Rna nanoparticle for liver cancer treatment P Guo, S Ellipilli, H Wang, XU Congcong, X Li US Patent App. 17/757,303, 2022 | | 2022 |
| Optimizing the Physicochemical Properties of RNA Nanoparticles for Controllable Drug Release, Hydrophobic Drug Encapsulation and Enhanced Cancer Targeting C Xu The Ohio State University, 2020 | | 2020 |
| LinearDesign: Efficient Algorithms for Optimized mRNA Sequence Design (preprint) H Zhang, L Zhang, Z Li, K Liu, B Liu, DH Mathews, L Huang | | 2020 |
Peixuan GuoThe Ohio State University在 osu.edu 的电子邮件经过验证
